LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) ...
SIOUX FALLS, SD / ACCESSWIRE / January 9, 2025 / Avel eCare, the nation's leading telemedicine provider of clinician-to-clinician services, is proud to announce the acquisition of Amwell Psychiatric ...
Offers an end-to-end platform for patient recruitment, data management, Biostatistics and regulatory submission FREMONT, CALIFORNIA / ACCESSWIRE / January 9, 2025 / CliniOps, Inc., a leading provider ...
Mark Orsmond, a highly respected business professional in Canadian Healthcare, Appointed Executive ChairMichael Nemirow Joins as Director, Bringing Decades of Entrepreneurial Expertise VANCOUVER, BC / ...
Lipozem: We Tested Lipozem Supplement - Here Is Our Honest Review NEW YORK CITY, NY / ACCESSWIRE / January 9, 2025 / In today's world, you will find a dozen ways to lose your weight and achieve your ...
Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...
The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend that the targeted drug olaparib can be used for locally advanced or metastatic breast cancer.
Alchemab Therapeutics (Alchemab), a biopharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies from resilient individuals, today announces it has entered a ...
Astraveus SAS (“Astraveus” or the “Company”), the Benchtop Cell Factory company, today announces the first ever successful end-to-end production of CAR-T cells within a microfluidic benchtop system.
Coave Therapeutics (‘Coave’), a company pioneering the future of genetic medicines, today announces the successful raising of €32 million ($33 Million) in Series A financing. The financing was co-led ...
Levels of LDL cholesterol, the so-called ‘bad’ cholesterol that blocks arteries, have been found to be 20% higher immediately after Christmas than during the summer. New research points to a definite ...
Results from the investigational, randomized, open-label IRAKLIA phase 3 study demonstrated that Sarclisa administered at a fixed dose subcutaneously (SC) via an on-body delivery system (OBDS) in ...